Display options
Share it on

Endocrine. 1995 May;3(5):315-8. doi: 10.1007/BF03021412.

Pituitary-adrenal axis function in systemic inflammatory response syndrome.

Endocrine

J A Tayek, V J Atienza

Affiliations

  1. Department of Medicine, Harbor-UCLA Medical Center, 90509, Torrance, California, USA.

PMID: 21153181 DOI: 10.1007/BF03021412

Abstract

This study characterizes the hypothalamic-pituitary-adrenal axis function in patients with sepsis syndrome now known as systemic inflammatory response syndrome (SIRS). One hundred and thirteen patients with SIRS had their pituitary-adrenal axis tested with the use of a 250 µg IV ACTH stimulation test. No patient received corticosteroids prior to the ACTH stimulation test. Serum cortisol concentrations were measured prior to and 30 and 60 min after ACTH administration. 26% of the patients had bacteremia, 22% bacteruria, 22% AIDS, 17% renal failure, 15% diabetes, 13% severe liver disease, 8% GI bleed, 4% pancreatitis, 3% trauma and 1% classical Addison's disease. Several patients had more than one disorder. The overall mortality was 28%. Multivariate analysis identified that both the baseline cortisol concentration and delta cortisol concentration were significant indicators of mortality. Despite the fact that mortality was double in the bacteremic patients, the baseline cortisol concentrations were similar to the non-bacteremic patients (25.4 ± 1.9vs 25.1 ± 2.5 µg/dl). The only cortisol abnormality noted in the bacteremic patients was a significantly smaller delta cortisol response to ACTH (14.7 ± 2.2vs 18.9 ± 1.2 µg/dl;P<0.05). These data imply that bacteremic processes may alter the adrenal responsiveness to intravenous ACTH administration. Understanding the pathophysiological disturbances responsible for an impaired adrenal reserve may identify new treatment strategies for patients with bacteremia.

References

  1. Crit Care Med. 1993 Sep;21(9):1339-47 - PubMed
  2. Thorax. 1989 May;44(5):422-4 - PubMed
  3. Ann Surg. 1977 Jul;186(1):29-33 - PubMed
  4. Ann Intern Med. 1986 Mar;104(3):410-8 - PubMed
  5. Endocrinology. 1992 Mar;130(3):1593-8 - PubMed
  6. Mayo Clin Proc. 1993 May;68(5):435-41 - PubMed
  7. Endocrinology. 1990 Jul;127(1):101-6 - PubMed
  8. Endocrinology. 1991 Jan;128(1):623-9 - PubMed
  9. Neuroendocrinology. 1993 Apr;57(4):593-9 - PubMed
  10. Chest. 1987 Aug;92(2):292-5 - PubMed
  11. Crit Care Med. 1985 Jun;13(6):477-9 - PubMed
  12. Crit Care Med. 1990 Mar;18(3):259-63 - PubMed
  13. J Clin Endocrinol Metab. 1956 Aug;16(8):1001-16 - PubMed
  14. Intensive Care Med. 1992;18(2):93-6 - PubMed
  15. Surgery. 1988 Aug;104(2):280-6 - PubMed
  16. J Clin Endocrinol Metab. 1985 Mar;60(3):444-50 - PubMed
  17. Clin Chem. 1974 Apr;20(4):411-4 - PubMed
  18. N Engl J Med. 1985 Feb 28;312(9):546-52 - PubMed
  19. Endocrinology. 1992 Mar;130(3):1413-23 - PubMed
  20. Endocrinology. 1993 Aug;133(2):815-21 - PubMed
  21. Endocrinology. 1993 Mar;132(3):946-52 - PubMed
  22. Lancet. 1991 Mar 9;337(8741):582-3 - PubMed
  23. Neuroimmunomodulation. 1994 Jan;1(1):14-22 - PubMed
  24. J Clin Endocrinol Metab. 1988 Aug;67(2):223-7 - PubMed
  25. Br J Dis Chest. 1986 Jan;80(1):7-12 - PubMed

Publication Types